These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34540994)

  • 1. Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors' Target Prediction.
    Li H; Mai Z; Yu S; Wang B; Lai W; Chen G; Zhou C; Liu J; Yang Y; Chen S; Liu Y; Chen J
    Biomed Res Int; 2021; 2021():4229194. PubMed ID: 34540994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.
    Jia X; Yang Y; Chen Y; Cheng Z; Du Y; Xia Z; Zhang W; Xu C; Zhang Q; Xia X; Deng H; Shi X
    J Affect Disord; 2019 Jan; 242():234-243. PubMed ID: 30212762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis of genome-wide data to identify potential pleiotropic genes for type 2 diabetes, obesity and coronary artery disease using MetaCCA.
    Jia X; Yang Y; Chen Y; Xia Z; Zhang W; Feng Y; Li Y; Tan J; Xu C; Zhang Q; Deng H; Shi X
    Int J Cardiol; 2019 May; 283():144-150. PubMed ID: 30459114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 67 Pleiotropic Genes Associated With Seven Autoimmune/Autoinflammatory Diseases Using Multivariate Statistical Analysis.
    Jia X; Shi N; Feng Y; Li Y; Tan J; Xu F; Wang W; Sun C; Deng H; Yang Y; Shi X
    Front Immunol; 2020; 11():30. PubMed ID: 32117227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Pleiotropic Genes for Immune and Skeletal Diseases Using Multivariate MetaCCA Analysis.
    He P; Cao RR; Deng FY; Lei SF
    Curr Genomics; 2021 Dec; 22(8):596-606. PubMed ID: 35386192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pleiotropic genes between risk factors of stroke by multivariate metaCCA analysis.
    Wang Z; Greenbaum J; Qiu C; Li K; Wang Q; Tang SY; Deng HW
    Mol Genet Genomics; 2020 Sep; 295(5):1173-1185. PubMed ID: 32474671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 Inhibitors' Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review.
    Khiali S; Taban-Sadeghi M; Sarbakhsh P; Khezerlouy-Aghdam N; Rezagholizadeh A; Asham H; Entezari-Maleki T
    J Clin Pharmacol; 2023 Dec; 63(12):1307-1323. PubMed ID: 37455561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate canonical correlation analysis identifies additional genetic variants for chronic kidney disease.
    Osborne AJ; Bierzynska A; Colby E; Andag U; Kalra PA; Radresa O; Skroblin P; Taal MW; Welsh GI; Saleem MA; Campbell C
    NPJ Syst Biol Appl; 2024 Mar; 10(1):28. PubMed ID: 38459044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Heart Failure Based on Network Pharmacology.
    Mai Z; Li H; Chen G; Chen E; Liu L; Lun Z; Lai W; Zhou C; Yu S; Liu J; Chen S; Chen J; Liu Y
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):713-726. PubMed ID: 34028657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end products using correlated meta-analyses: The Long Life Family Study.
    Feitosa MF; Lin SJ; Acharya S; Thyagarajan B; Wojczynski MK; Kuipers AL; Kulminski A; Christensen K; Zmuda JM; Brent MR; Province MA
    Aging Cell; 2024 Oct; 23(10):e14261. PubMed ID: 38932496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways.
    Yaribeygi H; Butler AE; Atkin SL; Katsiki N; Sahebkar A
    J Cell Physiol; 2018 Jan; 234(1):223-230. PubMed ID: 30076706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel SNPs associated with coronary artery disease and birth weight using a pleiotropic cFDR method.
    Wu X; Lin X; Li Q; Wang Z; Zhang N; Tian M; Wang X; Deng H; Tan H
    Aging (Albany NY); 2020 Dec; 13(3):3618-3644. PubMed ID: 33411684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing Genetic Pleiotropy with GWAS Summary Statistics for Marginal and Conditional Analyses.
    Deng Y; Pan W
    Genetics; 2017 Dec; 207(4):1285-1299. PubMed ID: 28971959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the effect of the SLC5A2 gene on eGFR: a Mendelian randomization study of drug targets for the nephroprotective effect of sodium-glucose cotransporter protein 2 inhibition.
    Liu G
    Front Endocrinol (Lausanne); 2024; 15():1418575. PubMed ID: 39268232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive gene-centric pleiotropic association analysis for 14 psychiatric disorders with GWAS summary statistics.
    Lu H; Qiao J; Shao Z; Wang T; Huang S; Zeng P
    BMC Med; 2021 Dec; 19(1):314. PubMed ID: 34895209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT2 inhibition and heart failure-current concepts.
    Custodio JS; Duraes AR; Abreu M; Albuquerque Rocha N; Roever L
    Heart Fail Rev; 2018 May; 23(3):409-418. PubMed ID: 29704192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When and How to Use Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction or Chronic Kidney Disease.
    O'Meara E; Verma S
    Can J Cardiol; 2021 Apr; 37(4):669-673. PubMed ID: 33450364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
    Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel variants associated with osteoporosis, type 2 diabetes and potentially pleiotropic loci using pleiotropic cFDR method.
    Hu Y; Tan LJ; Chen XD; Greenbaum J; Deng HW
    Bone; 2018 Dec; 117():6-14. PubMed ID: 30172742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional common loci associated with stroke and obesity identified using pleiotropic analytical approach.
    Wang L; Xu F; Brickell A; Sun N; Mao X; Zhang Q; Wang G; Zhou Q; Yang B; Li F; Yue L; Zhang W; Hao Y; Sun C
    Mol Genet Genomics; 2020 Mar; 295(2):439-451. PubMed ID: 31813042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.